Oral Solid Dose CDMOs

Thermo Fisher Scientific Inc.

China

One of the world's largest pharmaceutical CDMOs through its Patheon pharma services division. Provides end-to-end pharmaceutical development and manufacturing services for both small molecules and biologics, from API manufacturing through drug product, sterile fill/finish, packaging, and commercial supply. Operates 31+ FDA-registered facilities globally. 158 FDA inspections on record (52 NAI, 104 VAI, 2 OAI). Also provides cell therapy manufacturing solutions (CTS Rotea cell processing system), laboratory informatics, bioprocessing equipment, and reagents. 4 FDA-approved drug products. Revenue >$40B (full company).

Tiefenbacher Group

Cyprus

Purpose-driven, family-owned healthcare company pioneering healthcare since 1963, headquartered in Cyprus. Delivers best-in-class solutions across the entire pharmaceutical value chain from API distribution through development, manufacturing, and registration of affordable medicines. 900+ employees, 400+ customers, 180+ finished dosage form products, serving patients in 80+ countries. Production capacity up to 3 billion units per year. Manufacturing sites in Cyprus (large-scale oral solid dose, SPC waiver site) and Hyderabad, India (specialized high-potent manufacturing block for oncology, FDA-inspected). Includes Tiefenbacher Laboratories (TBD Pharmatech) as API CDMO division. Offers ICH stability studies, technology transfer, analytical laboratory services, and EU batch testing/release.

Tiofarma

Netherlands

Tiofarma is a Dutch CDMO specializing in complex semi-solid formulations (creams and ointments) and emergency nasal sprays, offering services from pre-formulation through commercial supply. The company operates an EU-GMP and FDA-licensed manufacturing facility in Oud-Beijerland, Netherlands, with in-house R&D and analytical laboratories.

T.Man Pharma Company Limited

Thailand

T.Man Pharma Company Limited is a Thai public company established in 1991, specializing in the production and distribution of modern drugs, herbal medicines, food supplements, cosmetics, and health products. With 500-999 employees, the company operates GMP PIC/s certified manufacturing facilities and serves both domestic and international markets. Listed as a CMO/CDMO on CPHI and registered with FDA Thailand.

Towa International

Spain

Towa International is the international hub of Japanese generics company Towa Pharmaceutical, headquartered in Barcelona, Spain. The company researches, develops, manufactures, and distributes generic and value-added medicines worldwide, with direct presence in the US (via Breckenridge Pharmaceutical), Europe (Spain, Italy, Portugal), and 40+ countries. Towa International also operates a CMO/CDMO line, offering production capabilities to partners. It recently added a new high-containment area for potent APIs.

Tulip Lab Pvt Ltd

India

Tulip Lab Pvt Ltd is an Indian pharmaceutical manufacturing company headquartered in Mumbai. ISO 22000 certified and PIC/S certified, they manufacture allopathic and herbal products including tablets, capsules, liquids, and topicals. Their product range covers essential care, lifestyle diseases, cardiology, women's well-being, and metabolic disorders. They offer formulation development, private label, and contract manufacturing services with GMP-compliant facilities.

UI Pharmaceuticals

United States

UI Pharmaceuticals (UIP) is the largest and most experienced university-affiliated FDA-registered pharmaceutical manufacturing facility in the United States, operated by the University of Iowa. They offer comprehensive drug product CDMO services from formulation development through commercialization. In 2023, they launched a new 16,000 sq ft sterile processing facility with fill lines. They serve pharmaceutical, biotech, pediatrics, oncology, and research organizations worldwide.

Ultratech India Limited

India

Ultratech India Limited is an integrated Indian pharmaceutical company established in 1992, manufacturing pharmaceutical finished dosage forms, Active Pharmaceutical Ingredients, and drug intermediates. They specialize in pulmonary drug delivery systems (DPI and pMDI inhalation products) and offer Custom Research and Manufacturing Services (CRAMS) including custom synthesis, process development, private labeling, and contract manufacturing. Extensive API portfolio covers cardiovascular, antifungal, antihistamine, anti-asthmatics, antiviral, erectile dysfunction, and other therapeutic segments. WHO GMP, ISO 9001, ISO 14001 certified.

UNI-PHARMA S.A.

Greece

UNI-PHARMA S.A. is a major Greek pharmaceutical company (part of the Tsetis Group) with over 60 years of operations. It researches, develops, produces, and distributes pharmaceutical products, food supplements, and medical devices. It holds the first place in sales (units) among purely Greek companies in the Greek pharmaceutical market. The company offers contract manufacturing services (listed as CMO/CDMO on PharmaSource) while also marketing its own extensive portfolio of generic medicines across multiple therapeutic categories. Their product range includes a very wide array of small-molecule generics.

Unison Pharmaceuticals Private Limited

India

Unison Pharmaceuticals Private Limited is an Indian pharmaceutical company established in 1981, recognized as a Contract Manufacturing Organisation (CMO) providing quality and affordable medicines. They handle testing, production, and full packaging. The company website has minimal content but search results confirm they are a CMO supplying pharmaceutical formulations including tablets.

Upperton Pharma Solutions

United Kingdom

Upperton Pharma Solutions is a UK-based CDMO with an award-winning 60,000 sq ft development and manufacturing facility (Trent Gateway) in Nottingham. They provide integrated services from pre-clinical through late-phase manufacture for oral solids, nasal, pulmonary, and parenteral dosage forms. They recently built a new 7 million GBP sterile fill/finish manufacturing facility with MHRA submission. Services include formulation development, clinical supply manufacturing (Phase I-III), process scale-up and optimization, quality control, and analytical development and validation.

Xellia Pharmaceuticals

China

Xellia Pharmaceuticals is the global leader in fermentation-based non-beta-lactam anti-infective APIs and finished dosage forms (FDFs). With over 120 years of pharmaceutical manufacturing heritage, they supply APIs and sterile injectables to over 500 pharmaceutical companies across 80 countries. Also operates as a CMO for third-party sterile injectable production.

Xi'an Wanlong Pharmaceutical

China

Xi'an Wanlong Pharmaceutical Co., Ltd. is a comprehensive modern pharmaceutical enterprise founded in 1995, primarily producing formulations, APIs, and intermediates with GMP and DMF compliance. The Yangling facility spans 200,000 sq.m. with 18 production lines for injections, tablets, capsules, powder, and raw materials.

XL LABORATORIES PVT LTD

India

XL Laboratories Pvt Ltd is an EU GMP, PIC/s, TGA, and WHO GMP approved pharmaceutical formulations and nutraceuticals research and manufacturing company established in 2001. It holds Star Export House status from the Indian Ministry of Commerce for outstanding international market performance, with presence in 40+ countries.

YooYoung Pharmaceutical Co., Ltd.

South Korea

YooYoung Pharmaceutical Co., Ltd. is a South Korean pharmaceutical manufacturer founded in 1981. The company operates a KGMP-certified factory in Jincheon with capabilities for oral solid dosage (800 million tablets/year), ampoule injectables (25 million/year), and prefilled syringe injectables (15 million syringes/year after 2021 expansion). Offers CMO/contract manufacturing services and exports to Japan, Asia, Europe, and South America.

Zhejiang Ausun Pharmaceutical Co Ltd

China

Zhejiang Ausun Pharmaceutical Co., Ltd., established in 2010 and listed on the Shanghai Stock Exchange (2017), is a Chinese pharmaceutical company based in the Taizhou Bay Economic Development Zone, Zhejiang Province. The company specializes in R&D, production, and sale of formulations (capsules, tablets) and active pharmaceutical ingredients. They are FDA-registered (FEI 3009065969) with 3 FDA inspections (1 NAI, 2 VAI, 0 OAI), have 2 FDA-approved products (capsule and tablet, oral route), hold US DMF filings, and have participated in 1 clinical trial (Infectious Disease). They employ 1,000-4,999 people. Their website was blocked (403 WAF), so details come primarily from search results and FDA regulatory data.

Zydus Lifesciences Ltd

India

Zydus Lifesciences Ltd. (formerly Cadila Healthcare) is a major Indian pharmaceutical company headquartered in Ahmedabad, Gujarat, ranked 4th in the Indian pharma industry with 29,000+ employees globally. In June 2025, Zydus entered the global biologics CDMO business by acquiring Agenus Inc.'s U.S. manufacturing facilities in Emeryville and Berkeley, California for $75M upfront (plus $50M milestones), now operating as independent subsidiary Zylidac Bio LLC. These facilities provide end-to-end biologics development and manufacturing from pre-clinical to commercial stages, including monoclonal antibody manufacturing for Phase-3 immuno-oncology products (Botensilimab and Balstilimab). Zydus has 15 FDA-registered facilities, 156 FDA-approved products across capsules, tablets, creams, gels, injectables (including liposomal), ointments, suppositories, and transdermal patches. They have 58 FDA inspections (25 NAI, 28 VAI, 5 OAI) and 51 recalls (2 Class I, 40 Class II, 9 Class III). Manufacturing sites span Gujarat, Maharashtra, Goa, Himachal Pradesh, Sikkim (India), plus US (Vermont, Pennsylvania, Missouri) and Brazil. Their CDMO services are specifically the biologics arm through Zylidac Bio -- the broader Zydus business is primarily own-brand generic pharmaceuticals.

ACON Pharmaceuticals

United States

ACON Pharmaceuticals Inc is a specialty contract research organization (CRO) based in Cranbury, New Jersey, focused on drug product development. They specialize in drug delivery systems including siRNA, mRNA, liposomes, nanocrystals, and complex generics development via the 505(b)(2) pathway. They are primarily a development-focused CRO, not a manufacturing organization.

Adare Pharma Solutions

Italy

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services from product development through commercial manufacturing, focused on oral dosage forms. They specialize in taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. They have developed and manufactured more than 65 products sold in over 100 countries globally.

Adragos Pharma

Germany

Adragos Pharma is a globally operating CDMO headquartered in Munich, Germany, specializing in small molecule finished dosage forms. They operate six manufacturing sites across Europe and Japan: Athens (Greece, HPAPI capabilities), Halden (Norway, BFS sterile production), Jura (Switzerland, small-batch clinical/commercial), Kawagoe (Japan, ampoules and tablets), Livron (France, sterile liquids and suppositories), and Leipzig (Germany, semi-solid and non-sterile liquids).

Alcami

United States

Alcami is a US-based CDMO with 45+ years of experience providing integrated drug product manufacturing, laboratory services, and cGMP pharmaceutical storage. The company specializes in sterile fill-finish manufacturing (liquid and lyophilized injectables, prefilled syringes) and oral solid dose, with DEA licensing for controlled substances and EU/Annex 1 compliance.

Altasciences

Canada

Altasciences is a North American CRO/CDMO offering integrated early-phase drug development services. The company provides preclinical safety testing, clinical pharmacology (Phase I-II), bioanalysis, and manufacturing/analytical services including formulation development, drug product manufacturing (tablets, capsules, suspensions, creams, terminally sterilized injectables), and ICH stability testing, with DEA licensing for Schedule I-V substances.

Ameripharma Labs

United States

Ameripharma Labs is a US-based contract pharmaceutical manufacturer specializing in solid dose manufacturing and packaging for OTC, Rx, and dietary supplement products. The company operates FDA-registered facilities with capabilities in granulation, blending, tablet compression, coating, and both blister and bottle packaging with serialization.

Angelini Pharma (Angelini Fine Chemicals)

Italy

Angelini Fine Chemicals, part of the Angelini Pharma group, is a leading Italian API CDMO with over 50 years of experience in small molecule API development and manufacturing. They offer custom synthesis, process development, and commercial-scale API production for branded and generic pharmaceutical companies.

Anwita Drugs & Chemicals Pvt Ltd

India

Anwita Drugs is an Indian research-focused pharmaceutical company specializing in oral solid dosage forms (OSD), effervescent formulations, tablets, capsules, sachets, and nutraceutical supplements. They offer contract manufacturing (CRAMS) services, API & intermediate production, and finished dosage form manufacturing from their facility in Hyderabad.

Apace Packaging LLC

United States

Apace Packaging is a U.S.-based FDA-registered contract pharmaceutical packaging and manufacturing company. They specialize in pharmaceutical packaging (blistering, bottling, tube filling, sachet packaging, clinical trial packaging) and also perform liquid and semi-solid manufacturing (blending, tube filling). They are DEA-licensed for Schedule II-V controlled substances.

Apeloa Pharmaceutical

China

Apeloa Pharmaceutical is a major Chinese CDMO and API manufacturer, publicly traded as part of the Hengdian Group, with over 7,000 employees. They are China's #2 API exporter and a top-5 Chinese CDMO. Their services span API & intermediates, CDMO, finished dosage forms, and aesthetic/care ingredients, with seven API sites and two drug product sites. They have passed 20+ US FDA inspections.

Aphena Pharma Solutions

United States

Aphena Pharma Solutions is a U.S.-based contract pharmaceutical manufacturing and packaging company operating from two FDA-registered locations. They specialize in liquid dose manufacturing, oral solid dose packaging, blister packaging, bottling, tube filling, injectable assembly, and clinical packaging. They are DEA-licensed for Schedule II-V controlled substances and ISO 13485 certified for medical devices.

Argenta (Animal Health CRO/CDMO)

Germany

Argenta is the world's only global animal health contract research, development, and manufacturing organization (CRO/CDMO). They provide end-to-end support for veterinary medicinal products including immunologicals/vaccines, biological non-immunologicals, pharmaceuticals, and novel therapies. They offer contract manufacturing for both sterile and non-sterile animal health products, with FDA-registered facilities across multiple sites globally. Note: they serve the animal health market, not human pharmaceuticals.

Artesan Pharma

Germany

Artesan Pharma is a German full-service CDMO based in Luechow, specializing in pharmaceutical contract development and manufacturing with 501-1,000 employees. They provide services spanning formulation development to commercial manufacturing across multiple dosage forms including oral solid doses (tablets, capsules, pellets), sterile prefilled syringes with innovative production processes, and liquids. They also offer serialization, final packaging (blister), and terminal steam sterilization capabilities.

Aspire Pharmaceuticals (Aspire LLC)

United States

Aspire Pharmaceuticals (Aspire LLC) is a contract manufacturer specializing in softgel encapsulation and oral solid dosage forms. They offer proprietary technologies including GummiCore (gummy-centered softgels), Vecell Liposomes (liposomal delivery), and softgel manufacturing using tapioca, carrageenan, and gelatin. They also have FDA-approved inhaled and ophthalmic products in their portfolio.

Astrea Pharma

France

Astrea Pharma is a CDMO founded with the purpose of building a customer-focused manufacturing network covering development to commercial supply. They acquired the Fontaine-les-Dijon solid dose manufacturing site from Recipharm and offer oral solid dose and aseptic manufacturing capabilities from development through commercial supply, with a focus on efficiency and value in the pharma supply chain.

AustinPx

United States

AustinPx is a client-centric CDMO based in Georgetown, Texas, specializing in oral solid dosage formulation development and GMP manufacturing for preclinical through Phase II clinical supplies. They are the inventors of KinetiSol technology, a next-generation solvent-free amorphous solid dispersion (ASD) technology for poorly soluble APIs that offers a smaller ecological footprint and broader formulation design space compared to traditional methods like hot melt extrusion and spray drying. AustinPx provides technology-nonbiased, data-driven formulation strategies, with KinetiSol as a proprietary differentiation tool. They received the CPHI Accelerating Innovation Award and CPHI Pharma Award for Excellence in Drug Delivery Technologies in 2024.

Avara Pharmaceutical Services

United States

Avara Pharmaceutical Services is an international contract manufacturing organization (CMO) headquartered in Norman, Oklahoma, specializing in commercial-scale drug product manufacturing. Their core capabilities include oral solid dose (including potent compounds and targeted release formulations) with capacity of 1.5 billion doses per year, liquid and lyophilized sterile injectable fill-finish with terminal sterilization and high containment, and integrated packaging with serialization, automated inspection, and specialty packaging. Avara operates former branded pharmaceutical facilities in the US (Norman, Oklahoma and Arecibo, Puerto Rico) and Italy (Liscate), serving 40+ countries. Facilities hold approvals from FDA, DEA, ANVISA, MPA (Sweden), and other international agencies.

Avivia BV

Netherlands

Avivia BV is a Netherlands-based pharmaceutical development services company specializing in formulation development, analytical services, dissolution method development, and excipient analysis. Based at Novio Tech Campus in Nijmegen, Avivia bridges the gap from API to pharmaceutical formulations, offering reverse engineering, product characterization, competitor analysis, troubleshooting, and small-scale GMP batch manufacturing. Avivia was acquired by Ofichem Group (a CMO) in 2025 to expand formulation development capabilities. They operate as a CMO-independent development partner, selecting the best manufacturing facility for each product's commercial scale-up.

Basic Pharma

Netherlands

Basic Pharma is a full-service CDMO based in the Netherlands specializing in regulated pharmaceutical product development, manufacturing, and commercialization. They offer GMP-compliant manufacturing of medicinal products and formulations, active pharmaceutical ingredients, and analytical testing from lab scale to early clinical phase and beyond. Their state-of-the-art facility includes GMP-compliant clean rooms.

BDD Pharma

United Kingdom

BDD Pharma is a UK-based combined CDMO and CRO specializing in lean early-stage drug development. With over 25 years of experience, they provide formulation development, GMP manufacturing, and clinical testing under one roof. Their new GMP manufacturing facility in Glasgow has been approved by MHRA for investigational medicinal products (IMP) and placebo manufacturing.

Benta Lyon SAS

France

Benta Lyon SAS is a French pharmaceutical company and CDMO established nearly 50 years ago in Saint-Genis-Laval near Lyon. They specialize in the development and manufacturing of generic pharmaceutical products with GMP/BPF-certified production facilities. Their site covers 16 hectares and focuses on dry, paste, and non-sterile liquid dosage forms, with plans to add sterile injectable capabilities. Their sister company Strategie Sante provides regulatory affairs, product development, and market access support.

Biofarma S.p.A. (Biofarma Group)

Italy

Biofarma Group is an Italian CDMO partner specializing in the third-party development and manufacturing of dietary supplements (integratori alimentari), nutraceuticals, probiotics, medical devices, and cosmetics. The company provides contract manufacturing, R&D, formulation development, and packaging services. FDA-registered. This is primarily a health and beauty care CDMO, not a pharmaceutical drug manufacturer; their focus is on supplements, probiotics, and cosmetics rather than prescription drugs or biologics.

Bliss GVS Pharma Ltd.

India

Bliss GVS Pharma Ltd. is an Indian pharmaceutical company and the world's largest manufacturer of suppositories and pessaries, operating in 60+ international markets. The company operates six manufacturing units in Maharashtra and Daman with WHO-GMP and EU-GMP (PIC/S) approvals, producing suppositories, pessaries, tablets, dry syrups, dry powder injectables, ointments, creams, and gels. Bliss GVS offers contract manufacturing (CMO/CDMO) services alongside its own product portfolio.

Bluepharma

Portugal

Bluepharma is a Portuguese CRDMO with over 55 years of experience, offering an integrated approach from R&D through to commercial manufacturing of medicines. The company produces 2 billion units of oral solid pharmaceutical forms and has an industrial plant for high potency products. Bluepharma's facilities are EMA/Infarmed and FDA approved, and the company has expanded into advanced therapies beyond small molecules.

CannaPiece Corp

Canada

CannaPiece Corp is a Canadian contract manufacturer providing services to Licensed Producers in the cannabis market. Based in Pickering, Ontario, the company offers packaging, capsule fabrication, and product development services under GMP conditions, holding a Health Canada Drug Establishment License for processing and sales.

CD Formulation

United States

CD Formulation provides formulation development, analytical services, drug packaging, and pharmaceutical excipient solutions for pharmaceutical and biotechnology companies. The company offers contract manufacturing and contract research services including liposome cGMP manufacturing, accelerated stability studies, and a wide range of formulation types including oral solid, injectable, and topical formulations. They also supply pharmaceutical excipients and active pharmaceutical ingredients.

Cenexi

Belgium

Cenexi is a Belgian/French CDMO specializing in sterile products, biological and injectable pharmaceutical manufacturing. The company operates four manufacturing sites in Europe, including sites in Fontenay-sous-Bois and Herouville-Saint-Clair (France), Osny (France, for highly active solid pharmaceutical forms), and Belgium. Cenexi offers services from development to commercial production for pre-filled syringes, vials, lyophilized products, tablets, capsules, and syrups, with FDA-registered manufacturing operations.

Chempro Pharma

India

Chempro Pharma Pvt. Ltd. is an Indian CDMO and exporter of APIs, intermediates, KSM, impurities, pellets, and finished dosage forms (FDF). The company operates WHO/EU GMP-approved facilities and is ISO 9001 certified, with manufacturing sites in Vapi, Gujarat and Maharashtra. It provides contract manufacturing services for both APIs and finished formulations.

Cipla

China

Cipla is a major Indian multinational pharmaceutical company that manufactures and markets its own branded generic medicines globally. While Cipla has formed joint ventures with CDMOs like Kemwell Biopharma for biosimilar development, the company itself is a pharmaceutical manufacturer selling its own products, not a contract manufacturer for others.

Coating Place Inc

United States

Coating Place Inc is a Wisconsin-based pharmaceutical CDMO founded in 1976, specializing in Wurster fluid bed coating technology for oral solid dosage forms. The company operates FDA- and EMA-approved GMP facilities in Verona and Sauk City, Wisconsin, with 24 proprietary Wurster fluid bed coaters handling batches from 0.010 kg to 800 kg, and is DEA-licensed for Schedule I-V controlled substances. The company celebrated its 50th anniversary in 2026.

Codis

United States

Codis is a global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies. Formed through the integration of Particle Dynamics in the US and the Haverhill, UK facility previously operated by EUROAPI, the company operates over 400,000 sq ft of cGMP manufacturing space across three sites with a 30-year regulatory track record, and is the world's leading manufacturer of Sevelamer API producing hundreds of metric tons annually.